Search for: "PAR PHARMACEUTICALS COMPANIES, INC" Results 1 - 20 of 65
Sorted by Relevance | Sort by Date
RSS Subscribe: 20 results | 100 results
2 Apr 2013, 2:48 pm by Fraud Fighters
Last month, Par Pharmaceutical Companies Inc. pleaded guilty to federal criminal charges and agreed to settle civil allegations involving the company’s promotion of the drug Megace ES. [read post]
23 Jul 2007, 9:13 pm
By Sherri Oslick -- Ortho-McNeil, Inc. announced late last week that it has settled its lawsuit against Par Pharmaceutical Companies, Inc. and its subsidiaries, Par Pharmaceutical, Inc. and Kali Laboratories, Inc., over the patent covering Ortho's Ultracet ® (tramadol hydrochloride and acetaminophen, used to treat acute pain). [read post]
2 Apr 2013, 1:55 pm by fraudfighters
Last month, Par Pharmaceutical Companies Inc. pleaded guilty to federal criminal charges and agreed to settle civil allegations involving the company’s promotion of the drug Megace ES. [read post]
29 Sep 2017, 12:26 pm by Adam Weinstein
  IPOs and offerings of small pharmaceutical companies are incredibly risky – on par with the risks of penny stocks. [read post]
14 Aug 2011, 9:59 pm by Patent Docs
Par Pharmaceutical Inc. et al. 1:11-cv-00705; filed August 10, 2011 in the District Court of Delaware • Plaintiffs: Avanir Pharmaceuticals Inc.; Avanir Holding Company; Center for Neurologic Study • Defendants: Par Pharmaceutical Inc.; Par Pharmaceutical Companies Inc. [read post]
6 Feb 2011, 9:34 pm by Patent Docs
Par Pharmaceutical Inc. et al. 1:11-cv-00107; filed February 2, 2011 in the District Court of Delaware • Plaintiffs: Somaxon Pharmaceuticals Inc.; Procom One Inc. • Defendants: Par Pharmaceutical Inc.; Par Pharmaceutical Companies Inc. [read post]
15 Apr 2012, 8:47 pm by Patent Docs
Par Pharmaceutical Companies Inc. et al. 1:12-cv-00393; filed March 28, 2012 in the District Court of Delaware • Plaintiffs: Horizon Pharma Inc.; Horizon Pharma USA Inc. • Defendants: Par Pharmaceutical Companies Inc.; Par Pharmaceutical Inc. [read post]
5 Mar 2013, 1:56 am by Ben Vernia
On March 5, the Department of Justice announced that generic drug maker Par Pharmaceuticals, Inc., entered a guilty plea and agreed to pay a combined $45 million to settle criminal and civil charges that it promoted Megace ES off-label. [read post]
26 Sep 2010, 8:41 pm by Patent Docs
Par Pharmaceutical Companies, Inc. et al. 1:10-cv-07310; filed September 22, 2010 in the Southern District of New York • Plaintiff: Biovail Laboratories International SRL • Defendants: Par Pharmaceutical Companies, Inc.; Par Pharmaceuticals, Inc. [read post]
1 Nov 2015, 9:57 pm by Patent Docs
Par Pharmaceutical Inc. et al. 1:15-cv-00679; filed August 3, 2015 in the District Court of Delaware • Plaintiffs: Janssen Biotech Inc.; Janssen Oncology Inc.; Janssen Research & Development LLC • Defendants: Amneal Pharmaceuticals LLC; Amneal Pharmaceuticals of New York LLC; Par Pharmaceutical Inc.; Par Pharmaceutical Companies Inc. [read post]
1 Mar 2015, 9:59 pm by Patent Docs
Par Pharmaceutical, Inc. et al. 1:15-cv-01454; filed February 25, 2015 in the District Court of Massachusetts • Plaintiff: Shire LLC • Defendants: Par Pharmaceutical, Inc.; Par Pharmaceutical Companies, Inc. [read post]
25 Jan 2015, 9:10 pm by Patent Docs
• Defendants: Par Pharmaceutical Inc.; Par Pharmaceutical Companies Inc. [read post]
3 Sep 2018, 9:16 pm by Patent Docs
Par Pharmaceutical, Inc. 1-18-cv-01224; filed August 10, 2018 in the District Court of Delaware • Plaintiff: Horizon Therapeutics, LLC • Defendants: Par Pharmaceuticals, Inc., Par Pharmaceutical Companies, Inc. [read post]
12 Jul 2015, 9:59 pm by Patent Docs
Par Sterile Products, LLC et al. 2:15-cv-03852; filed June 9, 2015 in the District Court of New Jersey • Plaintiff: Fresenius Kabi USA, LLC • Defendants: Par Sterile Products, LLC; Par Pharmaceutical, Inc.; Par Pharmaceutical Companies, Inc. [read post]
30 Sep 2013, 8:12 am by Gene Quinn
District Court for the District of Delaware against Apotex Corp.; Hetero USA Inc.; Lupin Ltd.; Mylan Pharmaceuticals, Inc.; Par Pharmaceuticals, Inc.; Ranbaxy Laboratories Ltd.; and related companies and subsidiaries. [read post]
19 Oct 2012, 6:15 pm
The majority of the assets in these 18 markets would be divested to Par Pharmaceutical, Inc. [read post]